APA (7th ed.) Citation

PE, A., S, T., F, D., S, Z., MA, M., & M, S. (2025). Prenatal Elexacaftor/Tezacaftor/Ivacaftor Treatment Prevents Meconium Ileus, but Not Exocrine Pancreatic Insufficiency and Lung Disease in Infants With Cystic Fibrosis. Pediatric pulmonology, 60(6), e71168. https://doi.org/10.1002/ppul.71168

Chicago Style (17th ed.) Citation

PE, Aleksander, Thee S, Doellinger F, Zagkla S, Mall MA, and Stahl M. "Prenatal Elexacaftor/Tezacaftor/Ivacaftor Treatment Prevents Meconium Ileus, but Not Exocrine Pancreatic Insufficiency and Lung Disease in Infants With Cystic Fibrosis." Pediatric Pulmonology 60, no. 6 (2025): e71168. https://doi.org/10.1002/ppul.71168.

MLA (9th ed.) Citation

PE, Aleksander, et al. "Prenatal Elexacaftor/Tezacaftor/Ivacaftor Treatment Prevents Meconium Ileus, but Not Exocrine Pancreatic Insufficiency and Lung Disease in Infants With Cystic Fibrosis." Pediatric Pulmonology, vol. 60, no. 6, 2025, p. e71168, https://doi.org/10.1002/ppul.71168.